UK markets close in 2 hours 55 minutes

Axsome Therapeutics, Inc. (AXSM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.29-0.81 (-2.02%)
At close: 4:00PM EDT
39.60 +0.31 (+0.79%)
Pre-market: 08:32AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close40.10
Bid38.61 x 800
Ask40.50 x 800
Day's range38.90 - 40.98
52-week range19.38 - 87.24
Avg. volume1,447,223
Market cap1.481B
Beta (5Y monthly)2.23
PE ratio (TTM)N/A
EPS (TTM)-3.04
Earnings date08 Nov 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est86.21
  • Motley Fool

    3 Biotech Stocks That Could Rise 90% or More, According to Wall Street

    Are you looking for biotech stocks that could shoot higher? Wall Street analysts who cover the stocks on this list think they could provide some eye-popping gains. Every stock on this list has a consensus price target that's 91% above its present price.

  • Motley Fool

    Why Axsome Therapeutics Stock Rocketed Higher This Week

    Shares of the developmental-stage biotech Axsome Therapeutics (NASDAQ: AXSM) vaulted higher by a healthy 25% through Thursday's close this week, according to data from S&P Global Market Intelligence. The U.S. Food and Drug Administration (FDA) still hasn't issued a regulatory decision for the company's major depressive disorder drug candidate known as AXS-05. Axsome posted several job openings on its website and other social media sites, indicating a need for individuals to work on AXS-05's commercial launch.

  • Motley Fool

    1 Beaten-Down Stock With 10X Potential

    The biotech industry is an excellent place to start. Clinical trial victories and regulatory approvals can send shares of a biotech soaring, especially one with a relatively small stock market capitalization. Let's look closer at one biotech whose shares have been hammered over the past few months, Axsome Therapeutics (NASDAQ: AXSM), and consider why this company still has some serious potential.